Product Reports Resources Pricing Login Book a demo

AtriCure

Health Tech & Medtech · West Chester, United States · Founded 1994 · IPO 2005

Headquartered near Cincinnati, Ohio, AtriCure has assembled experts in the medical device industry to form a highly effective team

Valuation $1.74B
Revenue $606M
EBITDA $87M

Talent graph

AtriCure's talent

Book a demo to see the people
Employees mapped 1,381 incl. 1 AI specialist
Founders Hidden — book a demo/100 quality score
Key operators 30 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

2 investors on AtriCure's cap table

Sourced from Dealroom's funding and investor records.

Series A 2 investors entered at this stage
Camden Partners
Partisan Management Group

Global footprint

Where AtriCure has talent and traffic

Workforce by country
🇺🇸 United States · West Chester HQ
Book a demo for the full country breakdown
Web traffic by country
17K monthly visits
across markets
🇺🇸 United States68.2%
🇬🇧 United Kingdom10%
🇮🇳 India5.9%
🇯🇵 Japan5.3%
🇳🇬 Nigeria4.7%
Top 5 markets shown

Patent intelligence

$126M patent portfolio · 148 active families

Estimated portfolio value
$126M
7.2% of market cap · 27.5× smaller than top peer Mazor Robotics ($3.5B)
148 active patent families
Where AtriCure innovates Biomedical engineeringCorneal ablationGeneral surgeryAdventitiaAtrial Appendage

Where AtriCure concentrates vs peers

Each axis is a top-10 topic across AtriCure and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

AtriCure's 3 investments and acquisitions.

Every disclosed deal where AtriCure appeared as a backer or acquirer, 2013–2019. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across AtriCure's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        AtriCure's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        What the market is saying about AtriCure

        An AI-synthesized read of the highest-engagement posts about AtriCure on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See AtriCure on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.